4 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... hospitalization for acute ... Drug interactions ... Clopidogrel #plavix #antiplatelet ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... agents in the acute ... In the acute/early ... of patients who are ... ticagrelor #prasugrel #pharmacology
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... CABG) - As antiplatelet ... from IV to PO Antiplatelet ... and clopidogrel, are ... such that the drug
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
important to recognize Acute ... Cardiac cath if acute ... #differential #algorithm ... heartfailure #chf #criticalcare ... icu #clinical #pharmacology